Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
Clinical trial NCT02829814 · TERMINATED
Trial details
- NCT number
- NCT02829814
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-22
- Primary completion
- 2016-09-13
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.